Vasculitis and Alveolar Hemorrhage Flashcards
Typical Presentation of Takayasu Arteritis for pulmonary Patient?
- Young Females, Pulmonary Artery Aneurysm, Pulmonary artery Stenosis, Pulmonary Infarct
Polyarteritis Nodosa Involvement in lung?
Typically does not involve lungs. 3 NO’s (No ANCA, no glomerulonephritis, No Pulmonary capillaritis) . Rare Case reports of Bronchial Artery involvement.
What Disease process do you think about with Pulmonary Artery Aneurysm from Vasculitis?
Behcets Disease
Induction Agents for SEVERE GPA/MPA?
Rituxan or Cyclophosphamide
Maintenance therapies for SEVERE GPA/MPA?
- Rituxan
- Methotrexate or Azathiopurine
- Mycophenolate Mofetil or Leflunomide
Induction Agents for NON-severe GPA
Glucocorticoids + Methotrexate (First Line)
2nd Line Options are Glucocorticoids alone or +
- Rituxan
- Cyclophosphamide
- Azathiopurine
- Mycophenolate Mofetil
What did the PEXIVAS Trial Show?
No difference in outcomes leading to DEATH or ESRD in treating GPA patients with Plasma exchange or reduced dose Steroids alone regimen.
- What Risk do you have with Plex (Plasmapheresis).
- When Do you consider PLEX for treatment option of a Vasculitis?
- Increased Risk of Infection
- Consider with Patient being ANCA + And Anti-GBM, High-risk ERSD, Salvage/rescue therapy
Avacopan is a maintenance drug to prevent remission of Vasculitis, What is its mechanism of action?
C5a receptor Inhibitor
Damage to what tissue leads to Diffuse Alveolar Hemorrhage?
Alveolar Epithelium, Extracellular Matrix and Capillary Endothelium
> 20% Hemosiderin-Laden macrophages indicates what?
Diffuse Alveolar Macrophages.
Takes 6-8 weeks to go away.